Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic
Market Cap
$7.38 Billion
CN¥54.13 Billion CNY
Market Cap Rank
#2512 Global
#159 in China
Share Price
CN¥25.55
Change (1 day)
-0.78%
52-Week Range
CN¥23.20 - CN¥32.15
All Time High
CN¥85.06
About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, le… Read more

Shanghai Fosun Pharmaceutical Group Co Ltd (600196) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.022x

Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a cash flow conversion efficiency ratio of 0.022x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.34 Billion) by net assets (CN¥60.81 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Fosun Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥59.93 Billion CN¥4.48 Billion 0.075x -3.07%
2023-12-31 CN¥56.62 Billion CN¥4.36 Billion 0.077x -1.13%
2022-12-31 CN¥54.11 Billion CN¥4.22 Billion 0.078x -4.51%
2021-12-31 CN¥48.38 Billion CN¥3.95 Billion 0.082x +45.50%
2020-12-31 CN¥45.98 Billion CN¥2.58 Billion 0.056x -31.75%
2019-12-31 CN¥39.20 Billion CN¥3.22 Billion 0.082x -6.40%
2018-12-31 CN¥33.59 Billion CN¥2.95 Billion 0.088x +1.23%
2017-12-31 CN¥29.74 Billion CN¥2.58 Billion 0.087x +3.82%
2016-12-31 CN¥25.25 Billion CN¥2.11 Billion 0.084x +6.55%
2015-12-31 CN¥20.67 Billion CN¥1.62 Billion 0.078x +24.82%
2014-12-31 CN¥19.10 Billion CN¥1.20 Billion 0.063x +9.71%
2013-12-31 CN¥17.66 Billion CN¥1.01 Billion 0.057x +31.70%
2012-12-31 CN¥15.30 Billion CN¥665.52 Million 0.043x +56.15%
2011-12-31 CN¥11.37 Billion CN¥316.65 Million 0.028x +28.63%
2010-12-31 CN¥9.39 Billion CN¥203.36 Million 0.022x -42.52%
2009-12-31 CN¥6.95 Billion CN¥261.87 Million 0.038x -28.14%
2008-12-31 CN¥4.45 Billion CN¥233.04 Million 0.052x +72.08%
2007-12-31 CN¥4.32 Billion CN¥131.48 Million 0.030x -39.90%
2006-12-31 CN¥3.65 Billion CN¥184.91 Million 0.051x -22.64%
2005-12-31 CN¥2.88 Billion CN¥188.35 Million 0.066x -10.12%
2004-12-31 CN¥2.81 Billion CN¥205.10 Million 0.073x -2.08%
2003-12-31 CN¥2.02 Billion CN¥150.14 Million 0.074x +21.56%
2002-12-31 CN¥1.67 Billion CN¥102.47 Million 0.061x +18.84%
2001-12-31 CN¥1.32 Billion CN¥68.15 Million 0.052x -54.64%
2000-12-31 CN¥1.22 Billion CN¥138.43 Million 0.114x +95.42%
1999-12-31 CN¥657.08 Million CN¥38.20 Million 0.058x -53.64%
1998-12-31 CN¥530.77 Million CN¥66.55 Million 0.125x --